First report of eribulin in combination with pertuzumab and trastuzumab for advanced HER2-positive breast cancer.
| Image |  |
|---|---|
| Description | scientific article published on 26 June 2017 |
| Author/s |
author: Kazuhiro Araki Shunji Takahashi Yoshinori Ito Rie Horii Shinji Ohno Futoshi Akiyama |
| Publication date | June 27, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |